Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Epidemiology and Population Health

Obesity: a 100 year perspective

Abstract

This review has examined the scientific basis for our current understanding of obesity that has developed over the past 100 plus years. Obesity was defined as an excess of body fat. Methods of establishing population and individual changes in levels of excess fat are discussed. Fat cells are important storage site for excess nutrients and their size and number affect the response to insulin and other hormones. Obesity as a reflection of a positive fat balance is influenced by a number of genetic and environmental factors and phenotypes of obesity can be developed from several perspectives, some of which have been elaborated here. Food intake is essential for maintenance of human health and for the storage of fat, both in normal amounts and in obesity in excess amounts. Treatment approaches have taken several forms. There have been numerous diets, behavioral approaches, along with the development of medications.. Bariatric/metabolic surgery provides the standard for successful weight loss and has been shown to have important effects on future health. Because so many people are classified with obesity, the problem has taken on important public health dimensions. In addition to the scientific background, obesity through publications and organizations has developed its own identity. While studying the problem of obesity this reviewer developed several aphorisms about the problem that are elaborated in the final section of this paper.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Quetelet, Adolphe Sur l’homme et le developpement de ses facultes, ou essai de physique sociale; Paris: Bachelier, 1835 (Transl of L-A-J. A Treatise on Man and the Development of His Faculties. IN: Bray GA. The Battle of the Bulge: A History of Obesity Research. Pittsburgh: Dorrance Publishing, 2007 pp 423-36.

  2. Bray GA. Quetelet: quantitative medicine. Obes Res. 1994;2:68–71.

    Article  CAS  PubMed  Google Scholar 

  3. Bray GA. Beyond BMI. Nutrients. 2023;15:2254.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Flegal KM. Use and misuse of BMI categories. AMA J Ethics. 2023;25:E550–8.

    Article  PubMed  Google Scholar 

  5. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J Chr Diseases. 1972;25:329–43.

    Article  CAS  Google Scholar 

  6. Bray GA. Definition, measurement, and classification of the syndromes of obesity. Int J Obes. 1978;2:99–112.

    CAS  PubMed  Google Scholar 

  7. Garrow JS. Treat Obesity Seriouslv-A Clinical Manual. Edinburgh: Churchill Livingstone; 1981.

  8. Rodgers A, Woodward A, Swinburn B, Dietz WH. Prevalence trends tell us what did not precipitate the US obesity epidemic. Lancet Public Health. 2018;3:e162–3.

    Article  PubMed  Google Scholar 

  9. Bray GA. Body fat distribution and the distribution of scientific knowledge. Obes Res. 1996;4:189–92.

    Article  CAS  PubMed  Google Scholar 

  10. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79:379–84.

    Article  CAS  PubMed  Google Scholar 

  11. Weeks RW. An experiment with the specialized investigation. Actuar Soc Am Trans. 1904;8:17–23.

    Google Scholar 

  12. Vague J. La differenciation sexuelle facteur determinant des formes de l’obesite, Presse Medicale. 1947;55:339340. [Translated. IN: Bray GA. The Battle of the Bulge: A History of Obesity Research. Pittsburgh: Dorrance Publishing, 2007 pp 693–5].

  13. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr. 1956;4:20–34.

    Article  CAS  PubMed  Google Scholar 

  14. Larsson B, Svardsudd K, Welin L, Wihelmsen L, Bjorntorp P, Tibbllne G. Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13 year follow up of participants in the study of 792 men born in 1913. BMJ 1984;288:1401–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Bjorntorp P. Visceral obesity: a “civilization syndrome. Obes Res. 1993;1:206–22.

    Article  CAS  PubMed  Google Scholar 

  16. Behnke AR, Feen BG, Welham WC. The specific gravity of healthy men. JAMA 1942;118:495–8.

    Article  Google Scholar 

  17. Roentgen WC. Ueber eine neue Art von Strahlen. S.B. Phys-med Ges Wurzburg. 1895;132–41.

  18. Wong MC, Bennett JP, Leong LT, Tian IY, Liu YE, Kelly NN, et al. Monitoring body composition change for intervention studies with advancing 3D optical imaging technology in comparison to dual-energy X-ray absorptiometry. Am J Clin Nutr. 2023:S0002-9165(23)04152-7

  19. Church TS, Thomas DM, Tudor-Locke C, Katzmarzyk PT, Earnest CP, Rodarte RQ, et al. Trends over 5 decades in U.S. occupation-related physical activity and their associations with obesity. PLoS ONE. 2011;6:e19657 https://doi.org/10.1371/journal.pone.0019657.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Schwann TH; Smith H, Trans. Microsccopical researches into the accordance in the structure and growth of animals and plants. London: Sydenham Society 1847

  21. Hassall A. Observations on the development of the fat vesicle. Lancet. 1849;1:163–4.

    Google Scholar 

  22. Hirsch J, Knittle JL. Cellularity of human obese and nonobese adipose tissue. Fed Proc. 1970;29:1516–21.

    CAS  PubMed  Google Scholar 

  23. Garvey WT. New Horizons. A new paradigm for treating to target with second-generation obesity medications. JCEM. 2022;107:e1339–47.

    Article  PubMed  Google Scholar 

  24. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–32.

    Article  CAS  PubMed  Google Scholar 

  25. Lavoisier AL, DeLaPlace PS. Memoir on Heat. Read to the Royal Academy of Sciences 28 June 1783 [IN: Bray GA. The Battle of the Bulge: A History of Obesity Research. Pittsburgh: Dorrance Publishing, 2007 pp 498–512].

  26. Bray GA. Lavoisier and Scientific Revolution: The oxygen theory displaces air, fire, earth and water. Obes Res. 1994;2:183–8.

    Article  CAS  PubMed  Google Scholar 

  27. Helmholtz, Hermann von. Uber die Erhaltung der Kraft, ein physikalische Abhandlung, vorgetragen in der Sitzung der physicalischen Gesellschaft zu Berlin am 23sten Juli 1847. Berlin: G. Reimer, 1847.

  28. Bray GA. Commentary on Atwater classic. Obes Res. 1993;1:223–7.

    Article  CAS  PubMed  Google Scholar 

  29. Bray GA. Energy expenditure using doubly labeled water: the unveiling of objective truth. Obes Res. 1997;5:71–7.

    Article  CAS  PubMed  Google Scholar 

  30. Lifson N, Gordon GB, McClintock R. Measurement of total carbon dioxide production by means of D2018. J Appl Physiol. 1955;7:704–10.

    Article  CAS  PubMed  Google Scholar 

  31. Lichtman SW, Pisarska K, Berman ER, Pestone M, Dowling H, Offenbacher E, et al. Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med. 1992;327(Dec):1893–8.

    Article  CAS  PubMed  Google Scholar 

  32. Bray GA. Commentary on classics of obesity 4. Hypothalamic obesity. Obes Res. 1993;1:325–8.

    Article  CAS  PubMed  Google Scholar 

  33. Bruch H. The froehlich syndrome: report of the original case. Am J Dis Child. 1939;58:1281–90.

    Article  Google Scholar 

  34. Babinski JP. Tumeur du corps pituitaire sans acromegalie et arret de development des organs genitaux. Rev Neurol. 1900;8:531–3. [Translation IN: Bray GA. The Battle of the Bulge: A History of Obesity Research. Pittsburgh: Dorrance Publishing, 2007 pp 740–1]

    Google Scholar 

  35. Cushing H. The Pituitary Body and Its Disorders. Philadelphia. PA: JB Lippincott; 1912.

  36. Bray GA. Laurence, moon, Bardet Biedl: reflect a syndrome. Obes Res. 1995;3:383–6.

    Article  CAS  PubMed  Google Scholar 

  37. Laurence JZ, Moon RC. Four cases of “Retinitis Pigmentosa,” Occurring in the same family, and accompanied by general imperfections of development. Opthalmol Rev. 1866;2:32–41.

    Google Scholar 

  38. Bardet G. Sur un Syndrome d’Obesity Conginitale avec Polydactylie et Retinite Pigmentaire (Contribution a l’etude des formes clinique de 1 ’Obesite hypophysaire). Paris: 1920. Thesis [Translation IN: Bray GA. The Battle of the Bulge: A History of Obesity Research. Pittsburgh: Dorrance Publishing, 2007 pp 740–1].

  39. Biedl A. Geschwisterpaar mit adiposo-genitaler Dystrophie. Dtsch Med Woche. 1922;48:1630.

    Google Scholar 

  40. Cuenot L. Pure strains and their combinations in the mouse. Arch Zoot Exptl Gen. 1905;122:123.

    Google Scholar 

  41. Ingalls AM, Dickie MM, Snell GD. Obese, new mutation in the mouse. J Hered. 1950;41:317–8.

    Article  CAS  PubMed  Google Scholar 

  42. Coleman DL. Obesity and diabetes: two mutant genescausing obesity-obesity syndromes in mice. Diabetalogia. 1978;14:141–8.

    Article  CAS  Google Scholar 

  43. Zucker TF, Zucker LM. Fat accretion and growth in the rat. J Nutr. 1963;80:6–20.

    CAS  PubMed  Google Scholar 

  44. Schwartz MW, Seeley RJ, Zeltser LM, Drewnowski A, Ravussin E, Redman LM, et al. Obesity pathogenesis: an endocrine society scientific statement. Endocr Rev. 2017;38:267–96.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346:570–8.

    Article  CAS  PubMed  Google Scholar 

  46. Loos RJF, Yeo GSH. The genetics of obesity: from discovery to biology. Nat Rev Genet. 2022;23:120–33.

    Article  CAS  PubMed  Google Scholar 

  47. Blüher M. Metabolically healthy obesity. Endocr Rev. 2020;41:405–20.

    Article  Google Scholar 

  48. Acosta A, Camilleri M, Abu Dayyeh B, Calderon G, Gonzalez D, McRae A, et al. Selection of antiobesity medications based on phenotypes enhances weight loss: a pragmatic trial in an obesity clinic. Obes. 2021;29:662–71.

    Article  Google Scholar 

  49. Bray GA. Commentary on classics in obesity. 6. Science and politics of hunger. Obes Res. 1993;19:489–93.

    Article  Google Scholar 

  50. Cannon WB, Washburn AL. An explanation of hunger. Am J Physiol. 1912;29:441–54.

    Article  Google Scholar 

  51. Carlson AJ. Contributions to the physiology of the stomach -II. the relation between the concentrations of the empty stomach and the sensation of hunger. Am J Physiol. 1912;31:175–92.

    Article  Google Scholar 

  52. Carlson AJ. Control of Hunger in Health and Disease. Chicago, IL: University of Chicago Press; 1916.

  53. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest. 1998;101:515–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Bray GA. Eat slowly - From laboratory to clinic; behavioral control of eating. Obes Res. 1996;4:397–400.

    Article  CAS  PubMed  Google Scholar 

  55. Pavlov IP; Thompson WH, trans. The Work of the Digestive Glands. London: Charles Griffin and Co.; 1910.

  56. Skinner BF. Contingencies of Reinforcement: A Theoretical Analysis. New York: Meredith Corporation; 1969.

  57. Ferster CB, Nurenberger JI, Levitt EG. The Control of Eating. J. Math 1964;1:87-109.

  58. Stuart RB. Behavioral control of overeating. Behav Res Ther. 1967;5:357–65. [Also IN: Bray GA. The Battle of the Bulge: A History of Obesity Research. Pittsburgh: Dorrance Publishing, 2007 pp 793–9]

    Article  Google Scholar 

  59. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM. et a; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(Feb):393–403.

    CAS  PubMed  Google Scholar 

  60. The Look AHEAD Research Group, Wadden TA, Bantle JP, Blackburn GL, Bolin P, Brancati FL, Bray GA, et al. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity. 2014;22:5–13.

    Article  Google Scholar 

  61. Bray GA, Suminska M. From Hippocrates to the Obesity Society: A Brief History. IN Handbook of Obesity (Bray GA, Bouchard C, Katzmarzyk P, Kirwan JP, Redman LM, Schauer PL eds). Boca Raton: Taylor & Francis 2024. Vol 2, pp 3–16.

  62. Bray GA. Commentary on Banting Letter. Obes Res. 1993;1:148–52.

    Article  CAS  PubMed  Google Scholar 

  63. Banting W. Letter on Corpulence, Addressed to the Public. London: Harrison and Sons 1863. pp 1–21.

  64. Harvey W. On corpulence in relation to disease” With some remarks of diet. London” Henry Renshaw, 1872.

  65. Schwartz, H. Never Satisfied. A Cultural History of Diets, Fantasies and Fat. 1977.

  66. Foxcroft, Louise. Calories and Corsets. A history of dieting over 2000 years. London: Profile Books, 2011.

  67. Gilman, Sander L. Obesity. The Biography. Oxford: Oxford University Press, 2010.

  68. Linn R Stuart SL. The Last Chance Diet. A Revolutionary New Approach to Weight Loss 1977.

  69. Magendie F. Rapport fait a l’Academie des Sciences au le nom de la Commission diet la gelatine. C.R. Academie Sci (Paris) 1841:237-83.

  70. Bray GA. “The Science of Hunger: Revisiting Two Theories of Feeding. IN Bray GA. The Battle of the Bulge. A History of Obesity Research. Pittsburgh, Dorrance Publishing 1977 p. 238.

  71. Sours HE, Frattalli VP, Brand CD, et al. Sudden death associated with very low calorie weight regimes. Am J Clin Nutr. 1981;34:453–61.

    Article  CAS  PubMed  Google Scholar 

  72. Bray GA. From very-low-energy diets to fasting and back. Obes Res. 1995;3:207–9.

    Article  CAS  PubMed  Google Scholar 

  73. Benedict, F.G. A Study of prolonged fasting. Washington: Carnegie Institution of Washington (Publ No 203), 1915.

  74. Keys A, Brozek J, Henschel A, Mickelsen O,Taylor HL. The biology of human starvation. Minneapolis: University of Minnesota Press, 1950.

  75. Cahill GF Jr, Herrera MG, Morgan AP, Soeldner JS, Steinke J, Levy PL, et al. Hormone-fuel interrelationships during fasting. J Clin Invest. 1966;45:1751–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Benedict FG, Miles WR, Roth P, Smith HM. Human vitality and efficiency under prolonged restricted diet. Carnegie Instit Wash, Pub. No. 280. Washington: Carnegie Institution of Washington; 1919.

  77. Evans FA, Strang JM. The treatment of obesity with low-calorie diets. JAMA 1931;97:1063–8.

    Article  Google Scholar 

  78. Bloom WL. Fasting as an introduction to the treatment of obesity. Metabolism 1959;8:2 14–220.

    CAS  Google Scholar 

  79. Bray GA, Purnell JQ. An historical review of steps and missteps in the discovery of anti-obesity drugs. IN: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K, et al. editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2022.

  80. Lesses MF, Myerson A. Human autonomic pharmacology. NEJM 1938;218:119-24.

  81. Cohen PA, Goday A, Swann JP. The return of rainbow diet pills. Am J Public Health. 2012;102:1676–86.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Bray GA. Nutrient intake is modulated by peripheral peptide administration. Obes Res. 1995;3:569S–572S.

    Article  CAS  PubMed  Google Scholar 

  83. Kissileff HR, Pi-Sunyer FX, Thornton J, Smith GP. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am J Clin Nutr. 1981;34:154–60.

    Article  CAS  PubMed  Google Scholar 

  84. Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. STEP 1 study group. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989–1002.

    Article  CAS  PubMed  Google Scholar 

  85. Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, et al. SUSTAIN-6 investigators. semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375:1834–44.

    Article  CAS  PubMed  Google Scholar 

  86. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. SURMOUNT-1 investigators. tirzepatide once weekly for the treatment of obesity. N. Engl J Med. 2022;387:205–16.

    Article  CAS  PubMed  Google Scholar 

  87. Jastreboff AM, Kaplan LM, Frías JP, Wu Q, Du Y, Gurbuz S, et al. Retatrutide phase 2 obesity trial investigators. Triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial. N Engl J Med. 2023;389:514–26.

    Article  CAS  PubMed  Google Scholar 

  88. Bray GA. Obesity and surgery for a chronic disease. Obes Res. 1996;4:301–3.

    Article  CAS  PubMed  Google Scholar 

  89. Kremen AJ, Linner JH, Nelson CH. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg. 1954;140:439–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Payne JH, DeWind LT, Commons RR. Metabolic observations in patients with jejuno-colic shunts. Am J Surg. 1963;106:273–89.

    Article  CAS  PubMed  Google Scholar 

  91. Payne JH, DeWind LT. Surgical treatment of obesity. Am J Surg. 1969;118:141–6.

    Article  CAS  PubMed  Google Scholar 

  92. Buchwald H, Varco RL. Partial ileal bypass for hypercholesterolemia and atherosclerosis. Surg Gynecol Obstet. 1967;124:1231.

    CAS  PubMed  Google Scholar 

  93. Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am. 1967;47:1345–135.

    Article  CAS  PubMed  Google Scholar 

  94. O’Brien PE, MacDonald L, Anderson M, Brennan L, Brown WA. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013;257:87–94.

    Article  PubMed  Google Scholar 

  95. Arterburn D, Wellman R, Emiliano A, Smith SR, Odegaard AO, Murali S, et al. PCORnet bariatric study collaborative. Comparative effectiveness and safety of bariatric procedures for weight loss: a PCORnet cohort study. Ann Intern Med. 2018;169:741–50.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13:1–190.

    Article  CAS  PubMed  Google Scholar 

  97. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416–23.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273:219–34.

    Article  PubMed  Google Scholar 

  99. Sjöström L. Swedish Obese Subjects, SOS: A review of results from a prospective controlled intervention trial. In: Bray GA, Bochard C, eds. Handbook of Obesity, Volume 2: Clinical Applications. New York: Informa; 2014.

  100. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish Obese Subjects. N. Engl J Med. 2007;357:741–52.

    Article  PubMed  Google Scholar 

  101. Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012;307:56–65.

    Article  PubMed  Google Scholar 

  102. Carlsson LM, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish Obese Subjects. The New England. J Med. 2012;367:695–704.

    CAS  Google Scholar 

  103. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who would have thought it? an operation proves to be the most effective therapy for adult-onset. Diabetes Mellit Ann Surg. 1995;222:339–52.

    CAS  Google Scholar 

  104. Bray GA. Life insurance and overweight. Obes Res. 1995;3:97–99.

    Article  CAS  PubMed  Google Scholar 

  105. The Association of Life Insurance Medical Directors and The Actuarial Society of America. Medico- Actuarial Mortality Investigation. New York: The Association of Life Insurance Medical Directors and ‘The Actuarial Society of America; 1913.

  106. Keys A. Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Cambridge, MA: Harvard University Press; 1980.

  107. Dawber TR. The Framingham Study: The Epidemiology of Atherosclerotic Disease. Cambridge, MA: Harvard University Press; 1980.

  108. Bray, G.A. (Ed), Obesity in Perspective. Fogarty International Center Series on Preventive Med. Vol 2, parts 1 and 2, Washington, D.C.: U.S. Govt Prtg Office, 1976, DHEW Publication #75-708.

  109. Fryar CD, Carroll MD, Afful J. Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over: United States, 1960–1962 through 2017–2018. NCHS Health E-Stats. 2020.

  110. Bray GA. Obesity: Historical development of scientific and cultural ideas. Int J Obes. 1990;14:909–26.

    CAS  PubMed  Google Scholar 

  111. Bray GA. The Battle of the Bulge: A History of Obesity Research. Pittsburgh: Dorrance Publishing, 2007 p 30.

  112. Short, T. A Discourse Concerning the Causes and Effects of Corpulency Together with the Method for Its Prevention and Cure, J. Robert, London, 1727.

  113. Flemyng, M. A Discourse on the Nature, Causes and Cure of Corpulency, L Davis and C Reymers, London, 1760.

  114. Wadd, W. Comments on corpulency lineaments of leanness mems on diet and dietetics. London: John Ebers and Co, 1829.

  115. Chambers, TK. Corpulence, or excess fat in the human body. London: Longman, 1850.

  116. Rony HR. Obesity and Leanness. Philadelphia: Lea and Febiger, 1940.

  117. Rynearson EH, Gastineau CF. Obesity. Springfield, IL: Charles C. Thomas, 1949.

  118. Bray, G.A. The Obese Patient. Major Problems in Internal Medicine, Vol 9, Philadelphia, Pa.: W.B. Saunders Company, 1976, pp. 1-450.

  119. Bray G.A. A Guide to Obesity and the Metabolic Syndrome: Origins and Treatment. New York: CRC Press: Taylor and Francis Group. 2011.

  120. Howard AN. The history of the association for the study of obesity. Intern J Obes. 1992;16:S1–8.

    Google Scholar 

  121. Bray GA, Greenwood MRC, Hansen BC. The obesity society is turning 40: a history of the early years. Obesity. 2021;29(Dec):1978–81.

    Article  PubMed  Google Scholar 

  122. McLean Baird I, Howard AN. Obesity: Medical and Scientific Aspects: Proceedings of the First Symposium of the Obesity Association of Great Britain held in London, October 1968. Edinburgh & London: E. S. Livingston, 1968.

  123. Bray GA, Howard AN. Founding of the international journal of obesity: a journey in medical journalism. Int J Obes. 2015;39:75–9.

    Article  CAS  Google Scholar 

  124. Bray G. The founding of obesity research/obesity: a brief history. Obes. 2022;30:2100–2.

    Article  Google Scholar 

  125. Ziman J. The Force of Knowledge. The Scientific Dimension of Society. Cambridge: Cambridge University Press, 1976.

  126. Bray GA, Kim KK, Wilding JPH. Obesity: a chronic relapsing progressive disease process: a position paper of world obesity. Obes Rev. 2017;18:715–23.

    Article  CAS  PubMed  Google Scholar 

  127. Bray GA. Obesity is a chronic, relapsing neurochemical disease. Intern J Obes. 2004;28:34–8.

    Article  CAS  Google Scholar 

  128. Allison DB, Downey M, Atkinson RL, Billington CJ, Bray GA, Eckel RH, et al. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obes. 2008;16:1161–77.

    Article  Google Scholar 

  129. Garvey WT, Garber AJ, Mechanick JI, Bray GA, Dagogo-Jack S, Einhorn D, et al. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocr Pr. 2014;20:977–89.

    Article  Google Scholar 

  130. Bray GA, Ryan DH. Evidence-based weight loss interventions: individualized treatment options to maximize patient outcomes. Diabetes Obes Metab. 2021;23:50–62.

    Article  PubMed  Google Scholar 

  131. Ge L, Sadeghirad B, Ball GDC, da Costa BR, Hitchcock CL, Svendrovski A, et al. Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials. BMJ 2020;369:m696.

    Article  PubMed  PubMed Central  Google Scholar 

  132. Sjöström L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 1998;352:167–72.

    Article  PubMed  Google Scholar 

  133. Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 2006;295:761–75.

    Article  CAS  PubMed  Google Scholar 

  134. Foster GD, Wadden TA, Vogt RA, Brewer G. What is a reasonable weight loss? Patients’ expectations and evaluations of obesity treatment outcomes. J Consult Clin Psychol. 1997;65:79–85.

    Article  CAS  PubMed  Google Scholar 

  135. DiFeliceantonio AG, Coppin G, Rigoux L, Thanarajah ES, Dagher A, Tittgemeyer M, et al. Supra-additive effects of combining fat and carbohydrate on food reward. Cell Metab. 2018;28:33–44.e3.

    Article  CAS  PubMed  Google Scholar 

  136. Thanarajah SE, Backes H, DiFeliceantonio AG, Albus K, Cremer AL, Hanssen R, et al. Food intake recruits orosensory and post-ingestive dopaminergic circuits to affect eating desire in humans. Cell Metab. 2019;29:695–706.e4.

    Article  CAS  PubMed  Google Scholar 

  137. Bray GA. Is sugar addictive? Diabetes 2016;65:1797–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The author thanks Dr. Jennifer Lyn Baker for her helpful comments during the early stage of preparing this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

All contributions were made by the single author.

Corresponding author

Correspondence to George A. Bray.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

MSS # 2023IJO01171.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bray, G.A. Obesity: a 100 year perspective. Int J Obes (2024). https://doi.org/10.1038/s41366-024-01530-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41366-024-01530-6

Search

Quick links